We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+11.16%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$294M
AUM Growth
+$47M
Cap. Flow
+$52.7M
Cap. Flow %
17.92%
Top 10 Hldgs %
26.72%
Holding
84
New
21
Increased
28
Reduced
22
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 84.8%
2 Financials 1.81%
3 Industrials 0.84%
4 Energy 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMED icon
76
Globus Medical
GMED
$11.3B
-71,900
Closed -$1.71M
ISRG icon
77
Intuitive Surgical
ISRG
$141B
-44,100
Closed -$2.59M
PODD icon
78
Insulet
PODD
$9.89B
-39,400
Closed -$1.81M
SYK icon
79
Stryker
SYK
$131B
-54,500
Closed -$5.14M
VRTX icon
80
Vertex Pharmaceuticals
VRTX
$134B
-14,900
Closed -$1.77M
NUVA
81
DELISTED
NuVasive, Inc.
NUVA
-40,700
Closed -$1.92M
COV
82
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
-59,400
Closed -$6.08M
LPNT
83
DELISTED
LifePoint Health, Inc.
LPNT
-44,300
Closed -$3.19M
AGN
84
DELISTED
Allergan Inc
AGN
-29,700
Closed -$6.31M

Similar funds

Sivik Global Healthcare's Q1 2015 Portfolio in Review

As of Q1 2015, Sivik Global Healthcare held 84 positions worth $294M, up 19% from $247M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Sivik Global Healthcare deployed $52.7M of net new capital in Q1 2015, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Medtronic: 75,000 shares worth $5.85M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 90% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Amgen, an estimated $3.1M trimmed.

  • Sivik Global Healthcare's largest Q1 2015 buy was Medtronic: 75,000 shares worth $5.85M.
  • Sivik Global Healthcare added most to Gilead Sciences in Q1 2015, an estimated $5.11M increase.
  • Sivik Global Healthcare's biggest Q1 2015 reduction was Amgen, cutting an estimated $3.1M.
  • Sivik Global Healthcare fully exited Allergan Inc in Q1 2015, selling an estimated $6.31M.
  • Sivik Global Healthcare's ten largest holdings make up 27% of its $294M portfolio in Q1 2015.
  • Sivik Global Healthcare opened 21 new positions and closed 9 in Q1 2015.
  • Sivik Global Healthcare's portfolio value rose 19% quarter-over-quarter to $294M.

Based on Sivik Global Healthcare's 13F filing for Q1 2015, filed 1 Apr 2015.